Table 1.
Clinical characteristics of the study groups.
| TAV (n = 11) | BAV (n = 14) | C (n = 13) | |
|---|---|---|---|
| Male gender (%) | 46 | 59 | 60 |
| Age (years) | 64 ± 6 | 62 ± 4 | 40 ± 5 |
| Aortic diameter (cm) | 5.6 ± 0.18 | 5.9 ± 0.16 | <3 |
| Aortic CSA/h (cm2/m) | 6.6 ± 0.6 | 7.6 ± 0.6 | |
| Peak valve gradient (mmHg) | 83 ± 9 | 86 ± 11 | |
| Mean valve gradient (mmHg) | 55 ± 7 | 59 ± 9 | |
| Aortic valve area index (cm2/m2) | 0.39 ± 0.02 | 0.38 ± 0.02 | |
| Hypertension (%) | 84 | 81 | |
| Medication | |||
| Angiotensin receptor blockers (%) | 38 | 18 | |
| Statins (%) | 0 | 41 | |
| Aspirin (%) | 31 | 14 | |
Values are means ± S.E.M.